期刊文献+

血清乳酸脱氢酶水平对小细胞肺癌预后影响的Meta分析 被引量:9

Effects of serum LDH level on prognosis of small cell lung cancer:a meta-analysis
暂未订购
导出
摘要 目的评价血清乳酸脱氢酶水平对小细胞肺癌患者的预后影响。方法计算机检索PubMed、Embase、万方等数据库,并从符合纳入标准的文献中查找相关文献。对符合入选条件的文献数据进行Meta分析。结果纳入8个研究共1 671例小细胞肺癌患者。血清乳酸脱氢酶浓度高水平对患者的危害是低水平的1.25倍[95%CI(1.10,1.42),P=0.000]。结论治疗前血清乳酸脱氢酶浓度高水平的小细胞肺癌患者预后总生存率较低水平患者差,其水平对小细胞肺癌预后有一定的预测价值。 Objective To evaluate the prognostic impact of serum lactate dehydrogenase (LDH) level in patients with small cell lung cancer. Methods PubMed, Embase, Wanfang databases were searched for relevant studies thatassessed the prognostic relevance of serum LDH. Meta-analyses were conducted to estimate the summary incidence. Results A total of eight studies comprising of 1 671 patients met the inclusion criteria. Patients with high LDH levels were 1.25 times[95% CI (1.10,1.42) ,P = 0. 000 ] more at risk compared to those with low levels of LDH. Conclusion Patients with high levels of pre-treatment LDH have worse overall survival prognosis compared to those with low LDH levels, and LDH levels have predictive value to patients with small cell lung cancer.
出处 《实用肿瘤杂志》 CAS 2014年第1期48-51,共4页 Journal of Practical Oncology
关键词 小细胞 乳酸脱氢酶 预后 综合分析 carcinoma, small cell lactate dehydrogenase prognosis Meta-analysis
  • 相关文献

参考文献19

二级参考文献158

共引文献273

同被引文献68

  • 1郑晨宏,谢晓华.CIK细胞联合化疗对胃癌疗效的Meta分析[J].中国肿瘤生物治疗杂志,2015,22(3):363-368. 被引量:5
  • 2李勇,张湘茹,孙燕.小细胞肺癌患者预后的多因素分析[J].中国肺癌杂志,2006,9(6):525-529. 被引量:19
  • 3李高峰,蒋永新,王巍炜,巫正伟,郭刚.肺癌术后过继免疫治疗的近期疗效分析[J].肿瘤研究与临床,2007,19(2):99-100. 被引量:2
  • 4Bai Y, Sun Y, Peng J, et al. Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494 [ J]. Oncotarget,2014,5 ( 17 ) :7760 - 7775.
  • 5Xiao F, Bai Y, Chen Z, et al. Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100 [ J]. Eur J Cancer,2014,50( 8 ) : 1541 - 1554.
  • 6Li D, Masiero M, Banham AH, et al. The notch ligand JAGGED1 as a target for anti-tumor therapy [ J ]. Front Oncol,2014,4 (25) :254.
  • 7Pelullo M, Quaranta R, Talora C, et al. Notch3/Jaggedl circuitry reinforces notch signaling and sustains T-ALL [ J]. Neoplasia,2014,16 (12) : 1007 - 1017.
  • 8Qiu XX,Wang CH,You N, et al. High Jaggedl expression is associated with poor outcome in primary glioblastoma [ J]. Med Oncol,2015,32( 1 ) :341.
  • 9Xue TC, Zou JH, Chen RX, et al. Spatial localization of the JAG1/Notchl/osteopontin cascade modulates extrahepatic metastasis in hepatoeellular carcinoma [ J ]. Int J Oneol, 2014,45 ( 5 ) : 1883 - 1890.
  • 10Cao Z, Ding BS, Guo P, et al. Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance[ J]. Cancer Ce11,2014, 25 ( 3 ) :350 - 365.

引证文献9

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部